Assess accuracy of primary care asthma and COPD diagnosis using oscillometry and FeNO vs specialist diagnosis

Trial Identifier: D2287R00214
Sponsor: AstraZeneca
Start Date: December 2025
Primary Completion Date: April 2027
Study Completion Date: April 2027
Condition: Asthma; Chronic Obstructive Pulmonary Disease (COPD)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Argentina Buenos Aires, Argentina
Argentina Medoza, Argentina
Egypt Alexandria, Egypt
Egypt El Waili, Egypt
Mexico Monterrey, Mexico
Mexico Santiago de Quer taro, Mexico
Saudi Arabia Riyadh, Saudi Arabia
Taiwan Taichung, Taiwan
Taiwan Taoyuan City, Taiwan
United Arab Emirates Dubai, United Arab Emirates
Vietnam Hanoi, Vietnam
Vietnam Ho Chi Minh City, Vietnam